198 related articles for article (PubMed ID: 32983143)
1. Circulating and Salivary Antibodies to
Alkharaan H; Lu L; Gabarrini G; Halimi A; Ateeb Z; Sobkowiak MJ; Davanian H; Fernández Moro C; Jansson L; Del Chiaro M; Özenci V; Sällberg Chen M
Front Immunol; 2020; 11():2003. PubMed ID: 32983143
[TBL] [Abstract][Full Text] [Related]
2. Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.
Das KK; Geng X; Brown JW; Morales-Oyarvide V; Huynh T; Pergolini I; Pitman MB; Ferrone C; Al Efishat M; Haviland D; Thompson E; Wolfgang C; Lennon AM; Allen P; Lillemoe KD; Fields RC; Hawkins WG; Liu J; Castillo CF; Das KM; Mino-Kenudson M
Gastroenterology; 2019 Sep; 157(3):720-730.e2. PubMed ID: 31175863
[TBL] [Abstract][Full Text] [Related]
3. Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer.
Gaiser RA; Halimi A; Alkharaan H; Lu L; Davanian H; Healy K; Hugerth LW; Ateeb Z; Valente R; Fernández Moro C; Del Chiaro M; Sällberg Chen M
Gut; 2019 Dec; 68(12):2186-2194. PubMed ID: 30872392
[TBL] [Abstract][Full Text] [Related]
4. mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN).
Das KK; Xiao H; Geng X; Fernandez-Del-Castillo C; Morales-Oyarvide V; Daglilar E; Forcione DG; Bounds BC; Brugge WR; Pitman MB; Mino-Kenudson M; Das KM
Gut; 2014 Oct; 63(10):1626-34. PubMed ID: 24277729
[TBL] [Abstract][Full Text] [Related]
5. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
6. Integrated targeted metabolomic and lipidomic analysis: A novel approach to classifying early cystic precursors to invasive pancreatic cancer.
Gaiser RA; Pessia A; Ateeb Z; Davanian H; Fernández Moro C; Alkharaan H; Healy K; Ghazi S; Arnelo U; Valente R; Velagapudi V; Sällberg Chen M; Del Chiaro M
Sci Rep; 2019 Jul; 9(1):10208. PubMed ID: 31308419
[TBL] [Abstract][Full Text] [Related]
7. Cytology adds value to monoclonal antibody Das-1 testing for detection of high-risk pancreatic cysts.
Heidarian A; Das KK; Mino-Kenudson M; Fernandez-Del Castillo C; Pitman MB
J Am Soc Cytopathol; 2021; 10(3):249-254. PubMed ID: 33541830
[TBL] [Abstract][Full Text] [Related]
8. Humoral Predictors of Malignancy in IPMN: A Review of the Literature.
Nista EC; Schepis T; Candelli M; Giuli L; Pignataro G; Franceschi F; Gasbarrini A; Ojetti V
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884643
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].
Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G
Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626
[No Abstract] [Full Text] [Related]
10. Effect of Fusobacterium nucleatum on the T and B cell responses to Porphyromonas gingivalis in a mouse model.
Gemmell E; Bird PS; Carter CL; Drysdale KE; Seymour GJ
Clin Exp Immunol; 2002 May; 128(2):238-44. PubMed ID: 11985513
[TBL] [Abstract][Full Text] [Related]
11. Association of
Borowsky J; Haruki K; Lau MC; Dias Costa A; Väyrynen JP; Ugai T; Arima K; da Silva A; Felt KD; Zhao M; Gurjao C; Twombly TS; Fujiyoshi K; Väyrynen SA; Hamada T; Mima K; Bullman S; Harrison TA; Phipps AI; Peters U; Ng K; Meyerhardt JA; Song M; Giovannucci EL; Wu K; Zhang X; Freeman GJ; Huttenhower C; Garrett WS; Chan AT; Leggett BA; Whitehall VLJ; Walker N; Brown I; Bettington M; Nishihara R; Fuchs CS; Lennerz JK; Giannakis M; Nowak JA; Ogino S
Clin Cancer Res; 2021 May; 27(10):2816-2826. PubMed ID: 33632927
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm.
DiMaio CJ; Weis-Garcia F; Bagiella E; Tang LH; Allen PJ
Gastrointest Endosc; 2016 Jun; 83(6):1205-9. PubMed ID: 26408423
[TBL] [Abstract][Full Text] [Related]
13. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E
Yip-Schneider MT; Carr RA; Wu H; Schmidt CM
J Am Coll Surg; 2017 Oct; 225(4):481-487. PubMed ID: 28739154
[TBL] [Abstract][Full Text] [Related]
15. High-Grade Dysplasia in Resected Main-Duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) is Associated with an Increased Risk of Subsequent Pancreatic Cancer.
Majumder S; Philip NA; Singh Nagpal SJ; Takahashi N; Mara KC; Kendrick ML; Smyrk TC; Zhang L; Levy MJ; Gleeson FC; Petersen BT; Pearson RK; Topazian MD; Vege SS; Chari ST
Am J Gastroenterol; 2019 Mar; 114(3):524-529. PubMed ID: 30413822
[TBL] [Abstract][Full Text] [Related]
16. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
[TBL] [Abstract][Full Text] [Related]
17. Main pancreatic duct dilation greater than 6 mm is associated with an increased risk of high-grade dysplasia and cancer in IPMN patients.
Ateeb Z; Valente R; Pozzi-Mucelli RM; Malgerud L; Schlieper Y; Rangelova E; Fernandez-Moro C; Löhr JM; Arnelo U; Del Chiaro M
Langenbecks Arch Surg; 2019 Feb; 404(1):31-37. PubMed ID: 30612152
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytologic Evaluation of Intraductal Papillary Mucinous Neoplasm and Mucinous Cystic Neoplasms of Pancreas.
Gilani SM; Adeniran AJ; Cai G
Am J Clin Pathol; 2020 Sep; 154(4):559-570. PubMed ID: 32589187
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic Fluid Interleukin-1β Complements Prostaglandin E2 and Serum Carbohydrate Antigen 19-9 in Prediction of Intraductal Papillary Mucinous Neoplasm Dysplasia.
Simpson RE; Yip-Schneider MT; Flick KF; Wu H; Colgate CL; Schmidt CM
Pancreas; 2019 Sep; 48(8):1026-1031. PubMed ID: 31404023
[TBL] [Abstract][Full Text] [Related]
20. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas.
Amato E; Molin MD; Mafficini A; Yu J; Malleo G; Rusev B; Fassan M; Antonello D; Sadakari Y; Castelli P; Zamboni G; Maitra A; Salvia R; Hruban RH; Bassi C; Capelli P; Lawlor RT; Goggins M; Scarpa A
J Pathol; 2014 Jul; 233(3):217-27. PubMed ID: 24604757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]